Pharma Inc gets back to life beyond Covid

August 1, 2022

For Sun Pharma, its investment in speciality business is paying off, as it is becoming a driver of growth for the company’s US business. Cipla’s ‘One India’ strategy, focusing on branded prescription, trade generics and consumer health brands, is leading to continued core portfolio momentum across businesses.

More To Explore

Nestle India, Cochin Shipyard among top 10 stocks that LIC bought in Q3

LIC’s share by value in NSE-listed companies decreased to 3.51% in Q3 FY25, down from 3.59% in Q1 FY25, according to data from primeinfobase.com, an

February 5, 2025

Info Edge Q3 Results: Net profit jumps 60% YoY to Rs 243 crore, revenue rises 15%

Info Edge Q3 Results: The company’s revenue from operations rose 15.2% YoY to Rs 722.39 crore, up from Rs 627.12 crore in the same quarter

February 5, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003